Redhill Biopharma Ltd. (RDHL)

Trade RDHL now with
7/22/2021 9:20:42 AM RedHill Biopharma Announces Settlement Of Movantik Patent Litigation With Apotex
7/19/2021 7:08:17 AM RedHill Biopharma Announces Last Patient Out For Phase 2/3 COVID-19 Study Of Oral Opaganib
6/28/2021 7:09:39 AM RedHill Biopharma Says Opaganib Inhibits COVID-19 Variants In Preclinical Study
6/21/2021 7:16:50 AM RedHill Biopharma Presents Positive Oral Opaganib Phase 2 Data In COVID-19 At World Microbe Forum
6/7/2021 7:07:13 AM RedHill Biopharma Completes Enrollment Of Oral Opaganib Phase 2/3 COVID-19 Study
5/27/2021 7:19:07 AM RedHill Biopharma Q1 Loss Per Share $0.05, Flat With Last Year
5/24/2021 7:10:07 AM RedHill Biopharma Presents Analyses Of Movantik Onset Of Action And Symptom Improvement At DDW 2021
4/9/2021 7:02:08 AM RedHill Biopharma's Phase 2/3 COVID-19 Study Of Opaganib Gets Unanimous Recommendation To Continue
3/25/2021 9:17:06 AM RedHill Biopharma Reports Settlement Of Movantik Patent Litigation With MSN Pharmaceuticals
3/18/2021 7:21:49 AM RedHill Biopharma Q4 Net Revenues $21.5 Mln
3/2/2021 9:07:14 AM ObvioHealth And RedHill Biopharma Launch First In Kind Remote COVID-19 Therapy Trial Incorporating
2/23/2021 7:16:24 AM RedHill Biopharma Plans To Expand Phase 2/3 Study Of Opaganib In Patients With Severe COVID-19 To The U.S.
2/18/2021 7:14:27 AM RedHill Biopharma, Cosmo Pharma Sign Manufacturing Agreements For Movantik And RHB-204
2/17/2021 7:22:10 AM RedHill Biopharma Says First Patient Dosed In U.S. Phase 2/3 COVID-19 Outpatient Study With RHB-107